Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million
March 15, 2024 08:26 ET
|
Eupraxia Pharmaceuticals Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the...
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million
March 12, 2024 09:31 ET
|
Eupraxia Pharmaceuticals Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the...
Eupraxia Pharmaceuticals Announces Overnight Marketed Offering of Approximately $30 Million
March 11, 2024 16:08 ET
|
Eupraxia Pharmaceuticals Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the...
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering
April 12, 2022 09:49 ET
|
Eupraxia Pharmaceuticals Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the...
Eupraxia Pharmaceuticals Announces Overnight Marketed Offering
April 11, 2022 16:03 ET
|
Eupraxia Pharmaceuticals Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, April 11, 2022 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the...